Skip to main content
Fig. 2 | BMC Medical Imaging

Fig. 2

From: Application value of the treatment of breast cancer bone metastases with radioactive seed 125I implantation under CT-guidance

Fig. 2

Comparison of CA153 levels between the two groups (x ± s). Note: The abscissa represents the experimental group and the control group after treatment, and the ordinate represents the level of CA153, (U/mL); The level of CA153 in the experimental group was (16.1 ± 2.08) U/mL after treatment; The level of CA153 in the control group was (18.14 ± 2.31) U/mL after treatment; *Indicated significant difference in CEA level between the two groups after treatment (t = 4.402, P = 0.000)

Back to article page

BMC Medical Imaging

ISSN: 1471-2342

Contact us